IP Verse

Crystal Pharmatech competitive analysis

Loading summary...

Latest patents of Crystal Pharmatech opposed by its competitors

Explore Crystal Pharmatech's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3231805
Mar 4, 2020Salt Of Pyrrolo[2,3-D]Pyrimidine Compound And Novel Polymorph Of Salt1
EP3229799
Oct 17, 2018Crystalline Forms Of Trisodium Supramolecular Complex Comprising Valsartan And Ahu-377 And Methods Thereof1
EP3071554
Oct 3, 2018Crystalline Forms Of Lesinurad And Its Sodium Salt1

Latest publications and patents of Crystal Pharmatech New

Explore the latest publications and patents granted to Crystal Pharmatech, showcasing their recent innovations and technological advancements.

Last updated on: Oct 20, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Crystal Pharmatech

EP3231805
Mar 4, 2020Salt Of Pyrrolo[2,3-D]Pyrimidine Compound And Novel Polymorph Of SaltRevoked
EP3229799
Oct 17, 2018Crystalline Forms Of Trisodium Supramolecular Complex Comprising Valsartan And Ahu-377 And Methods ThereofRevoked
EP3071554
Oct 3, 2018Crystalline Forms Of Lesinurad And Its Sodium SaltOpposition Rejected

Latest PTAB cases involving Crystal Pharmatech

Discover the latest PTAB cases involving Crystal Pharmatech, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Crystal Pharmatech with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CRYSTAL PHARMATECH - 3 - -
D YOUNG29 - - -
HGF74 - - -
SCORPIO19 - - -